Coexistence of acquired protein S and protein C deficiency and the Arg506Gln mutation in factor Va in a child with severe thromboembolic disease

Acta Paediatrica, International Journal of Paediatrics

Volumn 87, Issue 3, 1998, Pages 349-350

  Shavit, I ^a   Brenner, B ^a   Lanir, N ^a   Kassis, I ^a   Lorber, A ^a   Shehadeh, N ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Arg506Gln mutation; Deep vein thrombosis; Embolism; Factor Va; Protein C; Protein S

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5A; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN;

ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CELLULITIS; CHILD; DEEP VEIN THROMBOSIS; DOPPLER FLOWMETRY; ETHNIC DIFFERENCE; FEMALE; GENE MUTATION; HUMAN; IMMOBILIZATION; LUNG EMBOLISM; LUNG SCINTISCANNING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; RISK ASSESSMENT; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA;

ALLELES; ANTICOAGULANTS; CHILD; DIAGNOSIS, DIFFERENTIAL; DISEASE-FREE SURVIVAL; FACTOR V; FEMALE; HUMANS; POINT MUTATION; PROTEIN C DEFICIENCY; PROTEIN S DEFICIENCY; THROMBOEMBOLISM; THROMBOPHILIA;

EID: 0031914694     PISSN: 08035253     EISSN: None     Source Type: Journal    
DOI: 10.1080/08035259850157462     Document Type: Article

References (14)

1. Dahlhack B. Inherited thromhophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Blood 1995; 85: 607-14
2. Bertina RM, Koeleman BPC, Koster T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7
3. Greengard JS, Sun X, Xu X, Fernandez JA, Griffin JH, Evatt B. Activated protein C resistance caused by Arg506Gln mutation in factor Va. Lancet 1994; 343: 1361-2
4. Koster T, Rosendaal FR, De Ronde H, Briet E, Vandenbroucke JP, Bertina RM. Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thromhophilia study. Lancet 1993; 342: 1503-6
5. Rosendaal FR, Koster T, Vanderbroucke JP, Reitsma PH. High risk of thrombosis in patients homozygotes for factor V Leiden (activated protein C resistance). Blood 1995; 85: 1504-8
6. Koeleman BPC, Reitsma PH, Allaart CF, Bertina RM. Activated protein C resistance as an additional risk factor for thrombosis in protein C-deficient families. Blood 1994; 84: 1031-5
7. Koeleman BPC, Van Rumpt D, Hamulyak K, Reitsma PH, Bertina RM. Factor V Leiden: an additonal risk factor for thrombosis in protein S deficient families? Thromb Haemost 1995; 74: 580-3
8. Vanderbroucke JP, Koster T, Briet E, Reitsma PH, Bertina RM, Rosendaal FR. Increased risk of venous thrombosis in oral-contraceptive users who are caries of factor V Leiden mutation. Lancet 1994; 344: 1453-7
9. Miletich JP. Laboratory diagnosis of protein C deficiency. Semin Thromb Hemost 1990; 16: 169-76
10. Brenner B, Vulfsons SL, Lanir N, Nahir M. Coexistance of familial antiphospholipid syndrome and factor V Leiden: impact on thrombotic diathesis. Br J Haematol 1996; 94: 166-7
11. Mandel H, Brenner B, Berant M, Rosenberg N, Lanir N, Jacobs C, Fowler B, Seligsohn U. Coexistance of hyperhomocysteinemia and factor V Leiden mutation: impact on expression of thrombosis. N Engl J Med 1996; 334: 763-8
12. Manco-Johnson MJ. Disorders of hemostasis in childhood: Risk factors for venous thromboembolism. Thromb Haemost 1997; 78: 710-4
13. David M, Andrew M. Venous thromboembolic complications in children. J Pediatr 1993; 123: 337-46
14. Sligsohn U, Zevelin A. Thrombophilia as multigenic disorder. Thromb Haemost 1997; 78: 297-301